Latest news
Scientists develop breakthrough culture system to unlock secrets of skin microbiome
The co-culture system for skin microbiome can help understand interactions between bacterial species, aiding the development of specialized skin treatments.
How protective antibodies get in malaria’s way
Researcher’s structural insights help reveal weak spot in parasite’s plan of attack which could help guide vaccine design.
Gut feelings: Social connections change our microbiomes
Friends tend to share common interests, tastes, lifestyles, and other traits, but a new Yale-led study demonstrates that similarities among buddies can also include the makeup of the microbes lining their guts.
The mystery of the secretly sexual lichens
Researchers were shocked to find that a type of lichen called Lepraria, long assumed to be asexual, still has the genes that govern sexual reproduction.
Study uncovers key heart responses to viral infection
Researchers at the University of Virginia have made a significant discovery that could change how doctors treat viral infections of the heart.
Scientist developing probiotics to combat bovine respiratory disease
A new research project aims to develop probiotics derived from healthy cattle to prevent bovine respiratory disease, which is estimated to be responsible for about 70 to 80 percent of feedlot illnesses, and between 40 and 50 percent of all feedlot deaths in the US.
Scientists develop breakthrough culture system to unlock secrets of skin microbiome
The co-culture system for skin microbiome can help understand interactions between bacterial species, aiding the development of specialized skin treatments.
How protective antibodies get in malaria’s way
Researcher’s structural insights help reveal weak spot in parasite’s plan of attack which could help guide vaccine design.
Gut feelings: Social connections change our microbiomes
Friends tend to share common interests, tastes, lifestyles, and other traits, but a new Yale-led study demonstrates that similarities among buddies can also include the makeup of the microbes lining their guts.
Women’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
SLEEVER® and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal
SLEEVER®, and CARBIOS have unveiled the first innovation to emerge from their partnership: SEELCAP® ONEGO, the world’s first Home Compost biodegradable tamper evident seal which integrates the encapsulated enzyme CARBIOS Active.
Biofuel breakthrough: Rhodococcus strain N1-S transforms succinic acid production
A new study reveals that Rhodococcus aetherivorans strain N1-S boosts succinic acid yields by 6.5 times, promising a more efficient path to sustainable biofuels.
Probiotic delivers anticancer drug to the gut
Researchers have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.
Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi
Researchers have developed a new and convenient technique for building complex 3D microfluidic networks, using plants and fungi which grew their roots into a ‘soil’ medium of nanoparticles of glass (silica) and a cellulose based binding agent.
Therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies
Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
Scientist developing probiotics to combat bovine respiratory disease
A new research project aims to develop probiotics derived from healthy cattle to prevent bovine respiratory disease, which is estimated to be responsible for about 70 to 80 percent of feedlot illnesses, and between 40 and 50 percent of all feedlot deaths in the US.
New research could pave way for vaccine against deadly wildlife disease
A researcher has been awarded a $2.4 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to study the cause of Bang’s disease, Brucella abortus.
PHIOGEN announces collaboration with Live UTI Free to drive patient-focused clinical trials
A biotech company developing live biotherapeutic products for drug-resistant and recurrent bacterial infections, is collaborating with a patient research and advocacy organization to empower their clinical development efforts.
